Emily Harris

Boston, New York

Editorial Intern at Spectrum Autism Research

2nd-year med student @harvardmed | Journalist via @nyu_journalism | @williamscollege alum | she/her

Featured in: Favicon

nih.gov

jamanetwork.com Favicon

phys.org

unimelb.edu.au Favicon

spectrumnews.org Favicon

wiley.com

lightning100.com Favicon

thetransmitter.org Favicon

ncbi.nlm.nih.gov Favicon

pursuit.unimelb.edu.au + 1 more

Articles

Null and noteworthy

1 month ago | thetransmitter.org | Laura Dattaro |Emily Harris |Isabel Smith |Kate Tsiplova

Recent articles A monthly newsletter about neuroscience research that fails to support a hypothesis or replicates a previously proposed one. This edition of Null and Noteworthy—the first for The Transmitter—highlights new findings about the auditory steady-state response in people with schizophrenia that, all within one study, somehow packed in a null result and a failed replication.
WHO Announces Mpox Global Plan, Appeals for Funding

Sep 20, 2024 | jamanetwork.com | Samantha Anderer |Emily Harris

As the mpox virus continues to spread in Africa, the World Health Organization (WHO) has launched a global emergency response plan to limit transmission. As of June 2024, the agency reported, the outbreak has resulted in nearly 100 000 confirmed cases and 200 deaths, mostly in the Democratic Republic of Congo, but also in such neighboring countries as Burundi and Kenya. Both Sweden and Thailand have reported a single travel-related case each.
NIH: Routine Lab Tests Not a Reliable Way to Diagnose Long COVID

Sep 6, 2024 | jamanetwork.com | Samantha Anderer |Emily Harris

Since 2021, the US National Institutes of Health (NIH) has enrolled 90 000 people across more than 200 clinical sites as part of its RECOVER initiative to understand, identify, and treat post–COVID-19 condition, also known as long COVID. One goal of these studies has been to discover biomarkers that can help diagnose long COVID because symptoms are so wide-ranging.
As Mpox Cases Surge in Africa, WHO Declares a Global Emergency-Here’s What to Know

Aug 23, 2024 | jamanetwork.com | Emily Harris

The International Health Regulations Emergency Committee meeting on the upsurge of mpox was convened on August 14, 2024, by the WHO director-general [center]. Many of the challenges with surveillance and testing in Africa went unresolved during the months that the rest of the world thought it had the virus contained, experts said in interviews with JAMA Medical News.
WHO Launches First Global Guidelines for Quitting Tobacco

Aug 2, 2024 | jamanetwork.com | Emily Harris

The World Health Organization (WHO) recently introduced its first set of recommendations aimed at helping adults quit tobacco—a “milestone in our global battle against these dangerous products,” WHO Director-General Tedros Adhanom Ghebreyesus, PhD, MSc, said in a statement. The guidelines feature 9 strongly recommended methods. There are 1.25 billion tobacco users around the world, and 60% want to quit, according to the report.
Pharmacy Middlemen Profit at Patients’ Expense, Says FTC

Aug 2, 2024 | jamanetwork.com | Emily Harris

In 2022, the US Federal Trade Commission (FTC) launched an inquiry into the opaque business practices of pharmacy benefit managers (PBMs), which act as intermediaries between drug manufacturers, insurance plans, and pharmacies. Now, despite “delay tactics” from PBMs, the FTC recently published an interim report describing how these companies might harm patients’ ability to access and afford their prescription medications.
Systematic Review: Problems With Smell Tied to Increased Frailty Risk

Aug 2, 2024 | jamanetwork.com | Emily Harris

Systematic Review: Problems With Smell Tied to Increased Frailty Risk Olfactory Impairment and Frailty Brian Sheng Yep Yeo, MBBS (Singapore); Jun He Chan, MBBS (Singapore); Benjamin Kye Jyn Tan, MBBS (Hons) (Singapore); Xuandao Liu, MBBS (Singapore), MMed (ORL); Laura Tay, MBBS (Singapore), MMed (Internal Medicine), MCI (Singapore); Neville Wei Yang Teo, MBBS (Singapore), MMed (ORL); Tze Choong Charn, MBBS (Singapore), GDFM (Singapore), MMed (ORL), DOHNS (England) JAMA Otolaryngology–Head &...
More Data About Risks, Benefits Might Change Breast Cancer Screening Choice

Aug 2, 2024 | jamanetwork.com | Emily Harris |Wanda K. Nicholson |Michael Silverstein |John Wong

More Data About Risks, Benefits Might Change Breast Cancer Screening Choice US Preventive Services Task Force USPSTF Recommendation: Screening for Breast Cancer US Preventive Services Task Force; Wanda K. Nicholson, MD, MPH, MBA; Michael Silverstein, MD, MPH; John B. Wong, MD; Michael J. Barry, MD; David Chelmow, MD; Tumaini Rucker Coker, MD, MBA; Esa M.
Weight Loss Drugs Linked With Lower Risk of 10 Cancers

Aug 2, 2024 | jamanetwork.com | Emily Harris

People with type 2 diabetes who used glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had a lower risk of 10 types of so-called obesity-associated cancers than those who used insulin, according to findings from a retrospective cohort involving more than 1.65 million US participants. Obesity-associated cancers are those that are linked to excess body fat, which raises the risk of developing these cancers and having a worse prognosis.
Dementia Rates Have Fallen Over Time, But Some Risk Factors Are Rising

Aug 2, 2024 | jamanetwork.com | Emily Harris

The proportion of people diagnosed with and living with dementia has decreased over time in the US and in several European countries, according to a recent analysis of results from 27 cohort studies that collected data between 1947 and 2015. The lower rates of dementia were likely a product of increased education and fewer people smoking, the researchers concluded. The prevalence of other risk factors, however, including hypertension, diabetes, and obesity, have increased over time.